Ubs Asset Management Americas Inc Kura Oncology, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 152,132 shares of KURA stock, worth $865,631. This represents 0.0% of its overall portfolio holdings.
Number of Shares
152,132
Previous 131,718
15.5%
Holding current value
$865,631
Previous $1.15 Million
12.47%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding KURA
# of Institutions
190Shares Held
79MCall Options Held
76KPut Options Held
85.8K-
Bvf Inc San Francisco, CA7.75MShares$44.1 Million2.25% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.44MShares$42.3 Million2.15% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$39.6 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.57MShares$37.4 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$28.2 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $381M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...